http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100031190-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b31896b0595e5629c470c80b74b2d2e4 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fed1511f51ebf580d2fa158e9840a7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd7b2f65dcb82f2cb28c38a7ff7e5c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98b1c26c996c93f44d6cecabf1af7b7 |
publicationDate | 2010-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20100031190-A |
titleOfInvention | New Use of AVR-2 for the Diagnosis of Ovarian Cancer |
abstract | The present invention relates to a novel use of AGR-2 for the diagnosis of ovarian cancer. More particularly, the present invention provides a kit for diagnosing ovarian cancer comprising an antibody, primer or probe specific for AGR-2, a method for detecting AGR-2 protein from a sample to provide information necessary for diagnosing ovarian cancer, and The present invention relates to a method for screening an ovarian cancer therapeutic agent, which comprises selecting an agent that inhibits the expression of the AGR-2 gene. Since AGR-2 of the present invention is specifically overexpressed only in ovarian cancer tissues and shows a difference in expression amount according to the type of ovarian cancer, the diagnosis for ovarian cancer, disease progression, and prognosis before and after treatment It can be used as a marker. Furthermore, since AGR-2 is a protein secreted out of cells, ovarian cancer can be diagnosed early by confirming the presence of AGR-2 in the blood. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9574012-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013004076-A1 |
priorityDate | 2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 945.